Authors
Loading...
Randomized trial examines antithrombotic effects of GPIIb/IIIa receptor blockade, suggesting improved outcomes in cardiovascular events.
Barry S. Coller (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: